Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making
November 11, 2022
Tags:
Be The Match BioTherapies' Chris McClain explains how the Evidence Engine — being developed by IQVIA with support from a consortium of nonprofit organizations including Be The Match BioTherapies — is designed to provide the global data sets and analytical tools needed to support data-driven decision-making about cell therapies.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
.svg)
